Drugmaker GlaxoSmithKline this week granted a fourth license to a South African drug company to manufacture and sell generic versions of some of its antiretroviral medications. Under the agreement, Biotech Laboratories, a subsidiary of Afrika Biopharma, will be able to make and supply generic anti-HIV medications to both the public and private sectors in sub-Saharan Africa. "As a black economic empowerment company in South Africa, we can now also play a meaningful role in the fight against the so-called social diseases of Africa," said Shad Mapetla, head of Afrika Biopharma and CEO of Biotech. "The granting of this license by GlaxoSmithKline will help us do that." It was not reported exactly which drugs were covered by the generic license.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved















Charlie Kirk DID say stoning gay people was the 'perfect law' — and these other heinous quotes
These are some of his worst comments about LGBTQ+ people made by Charlie Kirk.